Made available in DSpace on 2022-05-01T09:00:51Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-08-01; Background Pulmonary sequelae (PS) in patients with chronic paracoccidioidomycosis (PCM) typically include pulmonary fibrosis and emphysema. Knowledge of the molecular pathways involved in PS of PCM is required for treatment and biomarker identification. Methodology/Principal findings This non-concurren...